Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Given the aggressive nature of PDAC and the limitations of current treatments, targeting ferroptosis has emerged as a promising therapeutic approach
The first compared GLP-1 receptor agonist users with nonusers among patients with obesity but without type 2 diabetes
Mechanisms of Liver Injury
This creates a powerful one-two punch: the medication works chemically to signal satiety, while the fiber adds a physical sense of fullness
US$ 28.30
US$ 23.65
US$ 24.90
US$ 24.70
